Stock VRNA VERONA PHARMA PLC
Add to a list
To use this feature you must be a member
Log inSign up

All News Verona Pharma plc

Equities

VRNA

US9250501064

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
15.31 USD +0.46% Intraday chart for Verona Pharma plc -4.91% -22.99%
Apr. 22 European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading MT
Apr. 16 European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update
AQ
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading
MT
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
MT
Piper Sandler Raises Verona Pharma's Price Target to $36 From $31, Keeps Overweight Rating
MT
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower
MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading
MT
Verona Pharma : Notice and Proxy Statement AGM 2024
PU
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)
PU
Verona Pharma : Notice and Proxy Statement AGM 2024
PU
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)
PU
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading
MT
Andrew Fisher Joins Verona Pharma as General Counsel
AQ
Verona Pharma plc Announces Management Changes
CI
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat
MT
Verona Pharma Shares Rise After Narrower-Than-Expected Q4 Loss
MT
Verona Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : Verona Pharma plc, Q4 2023 Earnings Call, Feb 29, 2024
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VRNA Stock
  4. News Verona Pharma plc